Stay updated on Nivolumab and Ipilimumab Combination Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.

Latest updates to the Nivolumab and Ipilimumab Combination Clinical Trial page
- Check2 days agoChange DetectedA sitewide NIH announcement says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check9 days agoChange DetectedThe ClinicalTrials.gov error page displays an updated site revision label, changing from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page's extensive list of study locations and several study documents/links have been removed, reducing visibility of where the trial is conducted and what documentation is available.SummaryDifference19%

- Check51 days agoChange DetectedRelated topics entries were removed from the study page, including Melanoma, the related topics heading, and MedlinePlus Genetics. This reduces cross-links in the related topics section.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page's revision reference changed from v3.6.5 to v3.6.6, indicating a new revision of the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab and Ipilimumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.